Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    16531613 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)
Conditions: Cardiovascular Disease;   Myocardial Infarction;   Stroke;   Cancer
Intervention: Drug: Folic acid, vitamin B6 and B12 or placebo
2 Completed 5-Methyltetrahydrofolate Survival and Inflammation in ESRD Patients
Conditions: Mortality;   Hyperhomocysteinemia;   Inflammation
Interventions: Drug: 5-MTHF (5-methyltetrahydrofolate);   Drug: folic acid

Indicates status has not been verified in more than two years